• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Amendment: SEC Form SCHEDULE 13G/A filed by Alignment Healthcare Inc.

    5/15/26 7:48:19 AM ET
    $ALHC
    Medical Specialities
    Health Care
    Get the next $ALHC alert in real time by email



    SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549


    SCHEDULE 13G


    UNDER THE SECURITIES EXCHANGE ACT OF 1934
    (Amendment No. 2)


    Alignment Healthcare, Inc.

    (Name of Issuer)


    Common Stock

    (Title of Class of Securities)




    01625V104

    (CUSIP Number)
    03/31/2026

    (Date of Event Which Requires Filing of this Statement)


    Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
    Checkbox checked   Rule 13d-1(b)
    Checkbox not checked   Rule 13d-1(c)
    Checkbox not checked   Rule 13d-1(d)




    schemaVersion:


    SCHEDULE 13G

    CUSIP Number(s):
    01625V104


    1Names of Reporting Persons

    Wellington Management Group LLP
    2Check the appropriate box if a member of a Group (see instructions)

    Checkbox not checked  (a)
    Checkbox not checked  (b)
    3Sec Use Only
    4Citizenship or Place of Organization

    MASSACHUSETTS
    Number of Shares Beneficially Owned by Each Reporting Person With:
    5Sole Voting Power

    0.00
    6Shared Voting Power

    14,895,474.00
    7Sole Dispositive Power

    0.00
    8Shared Dispositive Power

    17,098,936.00
    9Aggregate Amount Beneficially Owned by Each Reporting Person

    17,098,936.00
    10Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

    Checkbox not checked
    11Percent of class represented by amount in row (9)

    8.4 %
    12Type of Reporting Person (See Instructions)

    HC


    SCHEDULE 13G

    CUSIP Number(s):
    01625V104


    1Names of Reporting Persons

    Wellington Group Holdings LLP
    2Check the appropriate box if a member of a Group (see instructions)

    Checkbox not checked  (a)
    Checkbox not checked  (b)
    3Sec Use Only
    4Citizenship or Place of Organization

    DELAWARE
    Number of Shares Beneficially Owned by Each Reporting Person With:
    5Sole Voting Power

    0.00
    6Shared Voting Power

    14,895,474.00
    7Sole Dispositive Power

    0.00
    8Shared Dispositive Power

    17,098,936.00
    9Aggregate Amount Beneficially Owned by Each Reporting Person

    17,098,936.00
    10Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

    Checkbox not checked
    11Percent of class represented by amount in row (9)

    8.4 %
    12Type of Reporting Person (See Instructions)

    HC


    SCHEDULE 13G

    CUSIP Number(s):
    01625V104


    1Names of Reporting Persons

    Wellington Investment Advisors Holdings LLP
    2Check the appropriate box if a member of a Group (see instructions)

    Checkbox not checked  (a)
    Checkbox not checked  (b)
    3Sec Use Only
    4Citizenship or Place of Organization

    DELAWARE
    Number of Shares Beneficially Owned by Each Reporting Person With:
    5Sole Voting Power

    0.00
    6Shared Voting Power

    14,895,474.00
    7Sole Dispositive Power

    0.00
    8Shared Dispositive Power

    17,098,936.00
    9Aggregate Amount Beneficially Owned by Each Reporting Person

    17,098,936.00
    10Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

    Checkbox not checked
    11Percent of class represented by amount in row (9)

    8.4 %
    12Type of Reporting Person (See Instructions)

    HC


    SCHEDULE 13G

    CUSIP Number(s):
    01625V104


    1Names of Reporting Persons

    Wellington Management Company LLP
    2Check the appropriate box if a member of a Group (see instructions)

    Checkbox not checked  (a)
    Checkbox not checked  (b)
    3Sec Use Only
    4Citizenship or Place of Organization

    DELAWARE
    Number of Shares Beneficially Owned by Each Reporting Person With:
    5Sole Voting Power

    0.00
    6Shared Voting Power

    14,653,262.00
    7Sole Dispositive Power

    0.00
    8Shared Dispositive Power

    15,996,577.00
    9Aggregate Amount Beneficially Owned by Each Reporting Person

    17,098,936.00
    10Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

    Checkbox not checked
    11Percent of class represented by amount in row (9)

    7.8 %
    12Type of Reporting Person (See Instructions)

    IA


    SCHEDULE 13G

    Item 1. 
    (a)Name of issuer:

    Alignment Healthcare, Inc.
    (b)Address of issuer's principal executive offices:

    1100 West Town and, Country Road, Suite 1600, Orange CA 92868
    Item 2. 
    (a)Name of person filing:

    Wellington Management Group LLP Wellington Group Holdings LLP Wellington Investment Advisors Holdings LLP Wellington Management Company LLP
    (b)Address or principal business office or, if none, residence:

    c/o Wellington Management Company LLP, 280 Congress Street, Boston MA 02210
    (c)Citizenship:

    Wellington Management Group LLP - Massachusetts Wellington Group Holdings LLP - Delaware Wellington Investment Advisors Holdings LLP - Delaware Wellington Management Company LLP - Delaware
    (d)Title of class of securities:

    Common Stock
    (e)CUSIP No.:

    01625V104
    Item 3.If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
    (a)Checkbox not checked   Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
    (b)Checkbox not checked   Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
    (c)Checkbox not checked   Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
    (d)Checkbox not checked   Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
    (e)Checkbox checked   An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
    (f)Checkbox not checked   An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
    (g)Checkbox checked   A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
    (h)Checkbox not checked   A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
    (i)Checkbox not checked   A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
    (j)Checkbox not checked   A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J),
           please specify the type of institution:
    (k)Checkbox not checked   Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
     
    Item 4.Ownership
    (a)Amount beneficially owned:

    See the responses to Item 9 on the attached cover pages.
    (b)Percent of class:

    8.37  %
    (c)Number of shares as to which the person has:
     (i) Sole power to vote or to direct the vote:

    0

     (ii) Shared power to vote or to direct the vote:

    See the responses to Item 6 on the attached cover pages.

     (iii) Sole power to dispose or to direct the disposition of:

    0

     (iv) Shared power to dispose or to direct the disposition of:

    See the responses to Item 8 on the attached cover pages.

    Item 5.Ownership of 5 Percent or Less of a Class.
     
    Not Applicable
    Item 6.Ownership of more than 5 Percent on Behalf of Another Person.
     
    If any other person is known to have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, such securities, a statement to that effect should be included in response to this item and, if such interest relates to more than 5 percent of the class, such person should be identified. A listing of the shareholders of an investment company registered under the Investment Company Act of 1940 or the beneficiaries of employee benefit plan, pension fund or endowment fund is not required.


    The securities as to which this Schedule is filed are owned of record by clients of one or more investment advisers identified in Item 7 directly or indirectly owned by Wellington Management Group LLP. Those clients have the right to receive, or the power to direct the receipt of, dividends from, or the proceeds from the sale of, such securities. No such client is known to have such right or power with respect to more than five percent of this class of securities, except as follows: Not Applicable.
    Item 7.Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
     
    If a parent holding company has filed this schedule, pursuant to Rule 13d-1(b)(ii)(G), so indicate under Item 3(g) and attach an exhibit stating the identity and the Item 3 classification of the relevant subsidiary. If a parent holding company has filed this schedule pursuant to Rule 13d-1(c) or Rule 13d-1(d), attach an exhibit stating the identification of the relevant subsidiary.


    Pursuant to the instructions in Item 7 of Schedule 13G, the following lists the identity and Item 3 classification of each relevant entity that beneficially owns shares of the security class being reported on this Schedule 13G. Wellington Group Holdings LLP - HC Wellington Investment Advisors LLP - HC Wellington Management Global Holdings, Ltd. - HC One or more of the following investment advisers (the "Wellington Investment Advisers"): Wellington Management Company LLP - IA Wellington Management Canada LLC - IA Wellington Management Singapore Pte Ltd - IA Wellington Management Hong Kong Ltd - IA Wellington Management International Ltd - IA Wellington Management Japan Pte Ltd - IA Wellington Management Australia Pty Ltd - IA The securities as to which this Schedule is filed by Wellington Management Group LLP, as parent holding company of certain holding companies and the Wellington Investment Advisers, are owned of record by clients of the Wellington Investment Advisers. Wellington Investment Advisors Holdings LLP controls directly, or indirectly through Wellington Management Global Holdings, Ltd., the Wellington Investment Advisers. Wellington Investment Advisors Holdings LLP is owned by Wellington Group Holdings LLP. Wellington Group Holdings LLP is owned by Wellington Management Group LLP.
    Item 8.Identification and Classification of Members of the Group.
     
    Not Applicable
    Item 9.Notice of Dissolution of Group.
     
    Not Applicable

    Item 10.Certifications:
     
    By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under ?? 240.14a-11.

        SIGNATURE 
     
    After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

     
    Wellington Management Group LLP
     
    Signature:Matthew Revell
    Name/Title:Compliance Manager
    Date:05/15/2026
     
    Wellington Group Holdings LLP
     
    Signature:Matthew Revell
    Name/Title:Compliance Manager
    Date:05/15/2026
     
    Wellington Investment Advisors Holdings LLP
     
    Signature:Matthew Revell
    Name/Title:Compliance Manager
    Date:05/15/2026
     
    Wellington Management Company LLP
     
    Signature:Matthew Revell
    Name/Title:Compliance Manager
    Date:05/15/2026
    Get the next $ALHC alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ALHC

    DatePrice TargetRatingAnalyst
    4/17/2026$24.00Outperform
    Wolfe Research
    11/24/2025$20.00Neutral → Overweight
    Analyst
    10/14/2025$21.00Buy
    Goldman
    8/25/2025$21.00Sector Weight → Overweight
    KeyBanc Capital Markets
    7/31/2025$13.00Underweight → Equal Weight
    Barclays
    12/3/2024$13.00 → $17.00Equal-Weight → Overweight
    Stephens
    10/11/2024Sector Weight
    KeyBanc Capital Markets
    5/30/2024$10.00Outperform
    Robert W. Baird
    More analyst ratings

    $ALHC
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    President - MSO Kent Mark D. bought $197,627 worth of shares (14,848 units at $13.31) (SEC Form 4)

    4 - Alignment Healthcare, Inc. (0001832466) (Issuer)

    6/2/26 6:58:05 PM ET
    $ALHC
    Medical Specialities
    Health Care

    SEC Form 3 filed by new insider Hochradel Shane J.

    3 - Alignment Healthcare, Inc. (0001832466) (Issuer)

    6/2/26 6:52:15 PM ET
    $ALHC
    Medical Specialities
    Health Care

    SEC Form 3 filed by new insider Kent Mark D.

    3 - Alignment Healthcare, Inc. (0001832466) (Issuer)

    5/20/26 4:05:46 PM ET
    $ALHC
    Medical Specialities
    Health Care

    $ALHC
    SEC Filings

    View All

    Amendment: SEC Form SCHEDULE 13G/A filed by Alignment Healthcare Inc.

    SCHEDULE 13G/A - Alignment Healthcare, Inc. (0001832466) (Subject)

    5/15/26 4:05:34 PM ET
    $ALHC
    Medical Specialities
    Health Care

    Amendment: SEC Form SCHEDULE 13G/A filed by Alignment Healthcare Inc.

    SCHEDULE 13G/A - Alignment Healthcare, Inc. (0001832466) (Subject)

    5/15/26 7:48:19 AM ET
    $ALHC
    Medical Specialities
    Health Care

    SEC Form DEFA14A filed by Alignment Healthcare Inc.

    DEFA14A - Alignment Healthcare, Inc. (0001832466) (Filer)

    5/12/26 4:34:29 PM ET
    $ALHC
    Medical Specialities
    Health Care

    $ALHC
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Wolfe Research initiated coverage on Alignment Healthcare with a new price target

    Wolfe Research initiated coverage of Alignment Healthcare with a rating of Outperform and set a new price target of $24.00

    4/17/26 8:10:24 AM ET
    $ALHC
    Medical Specialities
    Health Care

    Alignment Healthcare upgraded by Analyst with a new price target

    Analyst upgraded Alignment Healthcare from Neutral to Overweight and set a new price target of $20.00

    11/24/25 8:06:33 AM ET
    $ALHC
    Medical Specialities
    Health Care

    Goldman initiated coverage on Alignment Healthcare with a new price target

    Goldman initiated coverage of Alignment Healthcare with a rating of Buy and set a new price target of $21.00

    10/14/25 8:46:39 AM ET
    $ALHC
    Medical Specialities
    Health Care

    $ALHC
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Alignment Healthcare Shows How Earlier, Coordinated Care Leads to Better Health and Fewer Emergencies in 2025 Impact Report

    ORANGE, Calif., June 02, 2026 (GLOBE NEWSWIRE) -- Alignment Healthcare, Inc. (NASDAQ:ALHC), today issued its 2025 Impact Report, detailing how its care model helps members stay healthier with earlier care and reduces the likelihood of emergencies and more serious health events. The report outlines Alignment's approach to coordinated, proactive care, resulting in fewer emergency room visits, hospital stays and post-acute care compared to Medicare fee-for-service benchmarks. As Alignment marks its fifth year as a publicly held company, the report also reflects a refreshed impact strategy centered on improving member health, advancing collaboration and growing responsibly. "From the start,

    6/2/26 8:00:00 AM ET
    $ALHC
    Medical Specialities
    Health Care

    Alignment Healthcare to Present at the Goldman Sachs 47th Annual Global Healthcare Conference 2026

    ORANGE, Calif., May 18, 2026 (GLOBE NEWSWIRE) -- Alignment Healthcare, Inc. (NASDAQ:ALHC), today announced that it will present at the Goldman Sachs 47th Annual Global Healthcare Conference 2026 in Miami, Florida, on Tuesday, June 9, at 10:40 a.m. EDT. A webcast and replay of the presentation will be available on Alignment's investor relations website at https://ir.alignmenthealth.com/. About Alignment HealthcareAlignment Health is championing a new path in senior care that empowers members to age well and live their most vibrant lives. A consumer brand name of Alignment Healthcare (NASDAQ:ALHC), Alignment Health's mission-focused team makes high-quality, low-cost care a reality for its

    5/18/26 8:00:00 AM ET
    $ALHC
    Medical Specialities
    Health Care

    Alignment Health Plan Recognized as One of Four Medicare Advantage Prescription Drug Plans in the U.S. for 2026 Excellence in Quality

    ORANGE, Calif., May 14, 2026 (GLOBE NEWSWIRE) -- Alignment Healthcare, Inc. (NASDAQ:ALHC) has been recognized for excellence in quality for its Medicare Advantage prescription drug (MAPD) plan by the Pharmacy Quality Alliance (PQA). Out of 613 eligible contracts, only 1.6% achieved recognition, highlighting the significance of this award. The recognition marks the seventh time Alignment has received this award, reinforcing its dedication to providing the best care for seniors. The PQA has measured medication safety for the Centers for Medicare and Medicaid Services (CMS) since 2006, ensuring medication safety, adherence and appropriate use. "We are incredibly honored that Alignment Healt

    5/14/26 4:01:00 PM ET
    $ALHC
    Medical Specialities
    Health Care

    $ALHC
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    President - MSO Kent Mark D. bought $197,627 worth of shares (14,848 units at $13.31) (SEC Form 4)

    4 - Alignment Healthcare, Inc. (0001832466) (Issuer)

    6/2/26 6:58:05 PM ET
    $ALHC
    Medical Specialities
    Health Care

    Kao John E bought $496,779 worth of shares (103,000 units at $4.82), increasing direct ownership by 4% to 2,745,253 units (SEC Form 4)

    4 - Alignment Healthcare, Inc. (0001832466) (Issuer)

    3/18/24 5:27:36 PM ET
    $ALHC
    Medical Specialities
    Health Care

    $ALHC
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by Alignment Healthcare Inc.

    SC 13G/A - Alignment Healthcare, Inc. (0001832466) (Subject)

    11/14/24 5:57:27 PM ET
    $ALHC
    Medical Specialities
    Health Care

    Amendment: SEC Form SC 13G/A filed by Alignment Healthcare Inc.

    SC 13G/A - Alignment Healthcare, Inc. (0001832466) (Subject)

    11/14/24 1:28:35 PM ET
    $ALHC
    Medical Specialities
    Health Care

    Amendment: SEC Form SC 13G/A filed by Alignment Healthcare Inc.

    SC 13G/A - Alignment Healthcare, Inc. (0001832466) (Subject)

    11/12/24 1:26:14 PM ET
    $ALHC
    Medical Specialities
    Health Care

    $ALHC
    Financials

    Live finance-specific insights

    View All

    Alignment Healthcare Delivers Strong First Quarter 2026 Results, Demonstrating Disciplined Growth and Margin Expansion

    Delivers $1.24 billion in total revenue, representing 33.3% growth year-over-yearGrows Medicare Advantage membership 30.9% year-over-year to approximately 284,800 membersRaises the midpoint of all guidance metrics: membership, revenue, adjusted gross profit and adjusted EBITDA ORANGE, Calif., April 30, 2026 (GLOBE NEWSWIRE) -- Alignment Healthcare, Inc. (NASDAQ:ALHC), today reported financial results for its first quarter ended March 31, 2026. "Our first-quarter performance demonstrates that Alignment continues to grow with discipline," said John Kao, founder and CEO. "We expanded our profitability by executing across sales, clinical operations and cost management, even as the Medicare A

    4/30/26 4:01:00 PM ET
    $ALHC
    Medical Specialities
    Health Care

    Alignment Healthcare to Announce First Quarter 2026 Financial Results and Host Conference Call Thursday, April 30, 2026

    ORANGE, Calif., April 09, 2026 (GLOBE NEWSWIRE) -- Alignment Healthcare, Inc. (NASDAQ:ALHC), will release its first quarter 2026 financial results on Thursday, April 30, 2026, after market close. Following the release, the company will host a conference call to review its financial results at 5 p.m. EDT. Conference Call DetailsA live audio webcast will be available online at https://ir.alignmenthealth.com/. At the start of the conference call, participants may access the webcast at the following link: https://edge.media-server.com/mmc/p/53zw9jkh A replay of the call will be available via webcast for on-demand listening shortly after the completion of the call at the same web links and w

    4/9/26 8:00:00 AM ET
    $ALHC
    Medical Specialities
    Health Care

    Alignment Healthcare Reports Fourth Quarter and Full-Year 2025 Results; Beats High-End of Guidance Across All Key Metrics

    Delivers full-year revenue of $3.95 billion, representing 46.1% growth year-over-year Exceeds high-end of fourth quarter and full-year guidance across all key metrics: membership, revenue, adjusted gross profit and adjusted EBITDARaises health plan membership guidance by 2,000 at the midpoint and introduces 2026 revenue guidance of $5.14 billion to $5.19 billion, representing 30%-31% growth year-over-year, and adjusted EBITDA of $133 million to $163 millionEarns recognition on the 2026 Fortune World's Most Admired Companies™ list, underscoring the company's innovative approach to senior health care ORANGE, Calif., Feb. 26, 2026 (GLOBE NEWSWIRE) -- Alignment Healthcare, Inc. (NASDAQ:ALHC),

    2/26/26 4:01:00 PM ET
    $ALHC
    Medical Specialities
    Health Care

    $ALHC
    Leadership Updates

    Live Leadership Updates

    View All

    Alignment Healthcare Set to Join S&P SmallCap 600

    NEW YORK, May 11, 2026 /PRNewswire/ -- Alignment Healthcare Inc. (NASD: ALHC) will replace Sun Country Airlines Holdings Inc. (NASD: SNCY) in the S&P SmallCap 600 effective prior to the opening of trading on Thursday, May 14. S&P SmallCap 600 constituent Allegiant Travel Co. (NASD: ALGT) is acquiring Sun Country Airlines Holdings in a deal expected to close soon, pending final closing conditions. Following is a summary of the changes that will take place prior to the open of trading on the effective date:Effective DateIndex Name       ActionCompany NameTickerGICS SectorMay 14, 2026S&P SmallCap 600AdditionAlignment HealthcareALHCHealth CareMay 14, 2026S&P SmallCap 600DeletionSun Country Airli

    5/11/26 6:21:00 PM ET
    $ALGT
    $ALHC
    $SNCY
    Air Freight/Delivery Services
    Consumer Discretionary
    Medical Specialities
    Health Care

    Alignment Health Appoints Adnan Mansour as Chief Digital Officer to Accelerate AI-Driven Growth and Technology Leadership

    ORANGE, Calif., Jan. 20, 2026 (GLOBE NEWSWIRE) -- Alignment Health, an award-winning Medicare Advantage (MA) company, today announced the appointment of Adnan Mansour as chief digital officer, an executive leadership role that unifies the company's technology and information functions to drive scalable growth and continued innovation. Mansour, formerly senior vice president and chief information officer at Optum Insight – the data, analytics and managed services division of UnitedHealth Group – brings decades of experience leading global IT and engineering teams and embedding artificial intelligence (AI) into complex health care systems. Effective Jan. 19, Mansour reports to Alignment Hea

    1/20/26 8:00:00 AM ET
    $ALHC
    Medical Specialities
    Health Care

    Alignment Healthcare Names Matt Eyles Executive Vice President of Government & Business Strategy

    ORANGE, Calif., Sept. 08, 2025 (GLOBE NEWSWIRE) -- Alignment Healthcare, Inc. (NASDAQ:ALHC) today announced that Matt Eyles will join as executive vice president of government and business strategy, effective Sept. 29. In this newly created position, Eyles will report directly to Alignment founder and CEO John Kao, elevating Alignment's engagement and leadership in health care policy at federal and state levels, leading innovative business planning to anticipate changes in the health care environment to drive growth, and developing new initiatives and partnerships aligned with enterprise priorities. "With Alignment's growing influence and impact, Matt's appointment comes at exactly the ri

    9/8/25 8:00:00 AM ET
    $ALHC
    Medical Specialities
    Health Care